**Update 11/11/20** – We received an email update from the site selector (and CEO) about their official site selection decision. The company is Vibalogics and they are locating in Boston, MA. See here for a press release: https://www.fiercepharma.com/manufacturing/new-ceo-board-germany-s-vibalogics-lays-out-150m-for-boston-viral-vector-site. Company is looking to accelerate their US expansion plans and global growth trajectory. They are looking to develop a late phase and commercial virus manufacturing facility on the East Coast. This is a qualified research project. If you need the preliminary project specs, please submit a response. We will try and get in contact with the project over 2 weeks. If there is no response to your submission, we will provide the projects contact information to you for personal use.